News

The CORDELIA study combines data from 35 Spanish cohorts (n = 196,632) to investigate genetic, clinical, and lifestyle risk ...
Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for diseases with high unmet need, today ...
We now have full genome sequences for six species of apes, helping us to pin down our last common ancestor – and potentially ...
The race to sequence the human genome was also billed as a race to end disease. So what happened? Watch the full video here: ...
A common assumption is that AGI won't need any further training by humans. The reality is that AGI will surely need to ...